BioSpace: Biotech, Pharmaceutical and Clinical Research News
WEB2024 Q2 Job Market Report: More People Competing for Fewer Job Openings. For the second quarter of 2024, there were 25% fewer jobs posted live on BioSpace compared to the same quarter of 2023. The year-over-year job response rate rose from 14.6% to 15.3%. July 11, 2024. ·.
News - BioSpace
WEBSeptember 12, 2024. ·. 4 min read. ·. Angela Gabriel. Load More. BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe. The latest biotech and pharmaceutical news ...
HEK 293 Cells: Background, Advantages and Applications
WEBJun 18, 2021 · Human Embryonic Kidney 293 (HEK 293) cells are one of the most frequently used cell lines for biotechnology and research studies. These cells are popular because they are fast-growing and robust. Additionally, due to the efficiency of HEK 293 cells, they generate exogenous proteins used in biomedical and pharmaceutical research.
Biopharma Mergers & Acquisitions - BioSpace
WEBLilly Inks Radiopharma Deal With Radionetics, Secures Right to Buy Biotech. Eli Lilly is expanding its radiopharmaceutical portfolio with a $140 million upfront payment to Radionetics Oncology and the exclusive future right …
BioSpace
WEBBioSpace
Lilly Opens $700M R&D Center in Boston for Genetic Medicines
WEBAug 14, 2024 · Eli Lilly on Tuesday debuted in America’s biggest biotech hub—Boston—with a new facility dedicated to the research and development of cutting-edge genetic therapies.. Dubbed the Lilly Seaport Innovation Center (LSC), the new site will expand the pharma’s U.S. footprint by 346,000 square feet and will be able to house 500 …
Genetown - BioSpace
WEBAug 27, 2024 · Genetown is comprised of Boston, Cambridge and the surrounding areas of Massachusetts. The area packs power in dynamo life sciences companies as well, in particular, cell and gene therapy, with the state’s drug development pipeline making up 14.9% of the U.S. total. The region is home to some of the nation’s most well-known and …
Novartis, Versant Launch RNA Kidney Medicines—Focused Borealis
WEBAug 22, 2024 · Novartis and Versant Ventures unveiled Borealis Biosciences Thursday with $150 million in combined Series A financing and strategic research collaboration funding to target next-generation RNA medicines for kidney diseases.. The Borealis collaboration builds on a previous kidney disease company. Five years ago, Versant launched …
Clinical research - BioSpace
WEBAug 12, 2024 · Pelage Pharmaceuticals Advances Clinical Program with First Patients Dosed in Phase 2 Study for Hair Loss and GV-Led $14M Series A-1. August 13, 2024. 4 min read. Sionna Therapeutics Announces Initiation of Two Phase 1 Clinical Trials of SION-719 and SION-451, in Development for Cystic Fibrosis.
Biotech Bay - BioSpace
WEBSep 13, 2024 · The Biotech Bay Hotbed includes the San Francisco Bay, Menlo Park and Palo Alto regions of Northern California. California is a dominant force in the life sciences sector, hosting global leaders and start-ups alike and is a center for cutting-edge science and medicine. Major research universities in the region, including Stanford University ...